Skip to main content

Closed

ENOV: Enovis Corporation Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+23.5% / yr

Operating margin2.7%

ROIC1.9%

Financially safe

Stretched

Debt / equity0.96×

Interest coverage1.1×

Current ratio2.04×

Enovis Corporation

ENOVNew York Stock Exchange·USD·Closed

Enovis Corporation

ENOVNew York Stock Exchange·USD·Closed

$29.15

−0.51%

$29.15

−$0.15 (0.51%)

52W Range

66thpctl

Volume

0.48×avg

Mkt Cap

1.68BUSD

P/E

-1.5TTM

Div Yield

–ann

52W Range

66thpctl

Volume

0.48×avg

Market Cap

1.68BUSD

P/E Ratio

-1.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings